Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 17 | 0 | 1 | 0 | €93.59 | €116.71 | 24.707% |
| Vertex Pharmaceuticals Inc. | 47 | 2 | 7 | 0 | €411.20 | €409.07 | -0.518% |
| Novavax Inc. | 8 | 1 | 6 | 0 | €13.85 | €27.38 | 97.694% |
| Dynavax Technologies Corp | 2 | 0 | 1 | 0 | €10.98 | €26.95 | 145.444% |
| Cytokinetics Inc. | 31 | 2 | 9 | 1 | €45.80 | €83.06 | 81.348% |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | €39.77 | €47.17 | 18.607% |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | €9.92 | €27.80 | 180.282% |
| Codexis Inc. | 6 | 2 | 2 | 0 | €3.14 | €8.36 | 165.878% |
| PTC Therapeutics Inc. | 15 | 8 | 3 | 3 | €33.00 | €41.51 | 25.795% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | €34.80 | €38.99 | 12.036% |
| Cara Therapeutics Inc. | 11 | 1 | 3 | 0 | €0.55 | €4.62 | 744.018% |
| Intra-Cellular Therapies Inc. | 25 | 0 | 2 | 0 | €60.00 | €79.55 | 32.591% |
| Ultragenyx Pharmaceutical Inc. | 18 | 1 | 2 | 0 | €36.00 | €82.93 | 130.364% |
| Akebia Therapeutics Inc. | 8 | 2 | 0 | 0 | €0.99 | €3.64 | 267.379% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.43 | - | - |
| Abeona Therapeutics Inc. | 4 | 1 | 1 | 0 | €3.90 | €33.73 | 764.831% |
| Syros Pharmaceuticals Inc. | 6 | 1 | 1 | 0 | €4.62 | €13.60 | 194.318% |
| MannKind Corp. | 8 | 0 | 1 | 0 | €4.15 | €6.03 | 45.241% |
| Zoetis Inc. A | 23 | 1 | 3 | 0 | €156.50 | €200.06 | 27.832% |
| Sutro Biopharma Inc | 21 | 0 | 3 | 0 | €3.98 | €11.04 | 177.447% |
| Phibro Animal Health Corp. A | 4 | 2 | 0 | 1 | €16.50 | €12.06 | -26.885% |
| Amicus Therapeutics Inc. | 7 | 0 | 4 | 0 | €9.10 | €17.64 | 93.821% |